Medical-grade Spore-free Natural Honey is an Effective Choleretic in Neonatal Cholestasis: A Pilot Single-center Trial
Gene Expression · 2023
DOI: 10.14218/ge.2022.00008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gene Expression, 2023. Verfasst von Magd A. Kotb und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Liver damage in cholestasis is multifactorial, yet bile acid-mediated hepatotoxicity is pivotal. Honey consumption has many physiological effects; it influences detoxification process (phase I, II and III), has antioxidant, anti-inflammatory, immune-stimulant, anti-ulcer, wound/burn healing effects and others. The bile acid ursodeoxycholic acid (UDCA) is currently used off-label to treat neonatal cholestasis. This study aimed to assess the effectiveness of spore-free natural honey to treat neonatal nonobstructive cholestasis.
Zitieren
APA
Kotb, M. A., Satar, E. A. E., Badr, A. M., Abdalla, N. A., & Abdelaziz, I. A. (2023). Medical-grade Spore-free Natural Honey is an Effective Choleretic in Neonatal Cholestasis: A Pilot Single-center Trial. Gene Expression. https://doi.org/10.14218/ge.2022.00008
Vancouver
Kotb MA, Satar EAE, Badr AM, Abdalla NA, Abdelaziz IA. Medical-grade Spore-free Natural Honey is an Effective Choleretic in Neonatal Cholestasis: A Pilot Single-center Trial. Gene Expression. 2023. doi:10.14218/ge.2022.00008
BibTeX
@article{Kotb2023,
author = {Kotb, Magd A. and Satar, Enas Abd El and Badr, Ahmed M. and Abdalla, Nazira A. and Abdelaziz, Iman A.},
title = {Medical-grade Spore-free Natural Honey is an Effective Choleretic in Neonatal Cholestasis: A Pilot Single-center Trial},
journal = {Gene Expression},
year = {2023},
doi = {10.14218/ge.2022.00008}
}
EUVIMED